We have developed a unique drug screening model utilizing a panel of Stem Cells (Primary Human Cells) from various parts of GI Tract. Primary Human GI Tract Cells are isolated from normal and diseased individuals and propagated in our in-house proprietary culture media. Our proprietary GI Tract Primary Human Cells can be used for target identification drug screening applications.

We have developed proprietary growth media where these cells grow for at least 12-15 passages. These cells are available from duodenum, esophagus, colon, small and large intestine and rectum. In-house study has established the stem cell nature of these cells.

If you are interested in these cells please contact sutton@alfagene.com for further information and licensing.